生物活性 | |||
---|---|---|---|
描述 | MS4077 is a PROTAC targeting on ALK with DC50 value of 3nM, consist of ALK inhibitor ceritinib as a warhead linked to CRBN ligand Pomalidomide. Treatment with MS4077 led a degradation of both ALK fusion protein, including NPM-ALK of SU-DHL-1 cells and EML4-ALK of NCI-H2228 cells, as well as downregulation of ALK auto phosphorylation and down-steam STAT3 phosphorylation, in both cell lines in a dose-dependent manner at concentration ranging in 1-100nM for 16h and in a time-dependent manner at concentration of 30nM for SU-DHL-1 cells or 60nM for NCI-H2228 cells within 24h. MS4077 exhibited potent antiproliferation against SU-DHL-1 cells with IC50 value of 46nM post 3 days. MS4748 and MS4740 work as the negative controls for MS4077[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
0.88mL 0.18mL 0.09mL |
4.41mL 0.88mL 0.44mL |
8.81mL 1.76mL 0.88mL |
参考文献 |
---|